Cohance Lifesciences (BOM:543064) Inventories, Finished Goods: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543064 Cohance Lifesciences Ltd BOM:543064
82 GF Score
Price ₹458.95
GF Value ₹797.62
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cohance Lifesciences Inventories, Finished Goods?

Cohance Lifesciences BOM:543064 -0.17% 82 Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543064 with a GF Score™ of 82/100 and a GF Value™ of ₹797.62 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Cohance Lifesciences's annual finished goods declined from Mar. 2024 (₹628 Mil) to Mar. 2025 (₹373 Mil) and declined from Mar. 2025 (₹373 Mil) to Mar. 2026 (₹0 Mil).

Cohance Lifesciences Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Cohance Lifesciences's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cohance Lifesciences Inventories, Finished Goods Chart

Cohance Lifesciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial 599.24 991.35 628.40 372.60 0.00

Cohance Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543064
82GF Score
Cohance Lifesciences Ltd BOM:543064
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cohance Lifesciences Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹0 Mil mean?
Cohance Lifesciences (BOM:543064) has a Inventories, Finished Goods of ₹0 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Cohance Lifesciences and its competitors.
Is Cohance Lifesciences' Inventories, Finished Goods too high?
Cohance Lifesciences' current Inventories, Finished Goods is ₹0 Mil. Overall, Cohance Lifesciences has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cohance Lifesciences' Inventories, Finished Goods compare to ZTS?
Cohance Lifesciences' Inventories, Finished Goods of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Cohance Lifesciences and its competitors. Cohance Lifesciences's current Inventories, Finished Goods is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cohance Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Cohance Lifesciences (BOM:543064) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹797.62, compared to a current price of ₹458.95 — trading 42.5% below its estimated fair value. The current Inventories, Finished Goods is ₹0 Mil. Cohance Lifesciences' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Cohance Lifesciences (BOM:543064), the current Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cohance Lifesciences (BOM:543064) Overvalued in 2026?

Based on GuruFocus' analysis, Cohance Lifesciences stock appears to be undervalued. The current stock price of ₹458.95 is trading 42.5% below its estimated GF Value™ of ₹797.62. GuruFocus considers Cohance Lifesciences to be Significantly Undervalued.

Key valuation signals for BOM:543064:

  • Inventories, Finished Goods: ₹0 Mil
  • GF Value™: ₹797.62 vs. price of ₹458.95 (42.5% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the BOM:543064 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cohance Lifesciences Business Description

Other Exchanges COHANCE:India
Address Hitech City Road, Panmaktha Plot, 1, 202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Opposite IKEA, Hyderabad, TG, IND, 500081
Cohance Lifesciences Ltd is a CDMO and API platform, offering products and services across all phases of a molecule's lifecycle from development to commercialization. Its Business Units comprise: CDMO, API+ and Formulations, and Clinical and Analytical Services.
82GF Score

Get the complete analysis for BOM:543064

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹458.95
Price
₹797.62
GF Value